Characterization of a Novel PTEN Mutation in MDA-MB-453 Breast Carcinoma Cell Line

BMC Cancer - United Kingdom
doi 10.1186/1471-2407-11-490
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Characterization of a Novel Breast Carcinoma Xenograft and Cell Line Derived From a BRCA1 Germ-Line Mutation Carrier

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2003English

Unusual Roles of Caspase-8 in Triple-Negative Breast Cancer Cell Line MDA-MB-231

International Journal of Oncology
Cancer ResearchOncology
2016English

Inhibition of MMP-3 Activity and Invasion of the MDA-MB-231 Human Invasive Breast Carcinoma Cell Line by Bioflavonoids

Acta Pharmacologica Sinica
MedicinePharmacology
2009English

Suppression of Spry4 Enhances Cancer Stem Cell Properties of Human MDA-MB-231 Breast Carcinoma Cells

Cancer Cell International
Cancer ResearchOncologyGenetics
2016English

Intrinsic Resistance to 5-Fluorouracil in a Brain Metastatic Variant of Human Breast Cancer Cell Line, MDA-MB-231BR

PLoS ONE
Multidisciplinary
2016English

Osteopontin Knockdown Suppresses Tumorigenicity of Human Metastatic Breast Carcinoma, MDA-MB-435

Clinical and Experimental Metastasis
MedicineCancer ResearchOncology
2006English

Proteomics Analysis of siRNA-mediated Silencing of Wilms’ Tumor 1 in the MDA-MB-468 Breast Cancer Cell Line

Oncology Reports
MedicineCancer ResearchOncology
2014English

Continued Use of MDA-MB-435, a Melanoma Cell Line, as a Model for Human Breast Cancer, Even in Year, 2014

npj Breast Cancer
OncologyRadiologyNuclear MedicinePharmacologyImaging
2015English

Anti-Cancer Effect of Apigenin on Human Breast Carcinoma MDA-MB-231 Through Cell Cycle Arrest and Apoptosis

Microbiology and Biotechnology Letters
Applied MicrobiologyBiotechnologyMicrobiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy